NCT06618391 2024-10-01
Local Injection and Systemic Therapy in the Treatment of NSCLC.
Henan Cancer Hospital
Phase 2 Not yet recruiting
Clinical Trials
11 trialsNCT05574998 2022-10-12
FTANLCNDG
Qianfoshan Hospital
Phase 2 Unknown
NCT05529355 2022-09-07
Effect and Safety of Envafolimab Combined With Endostar/S-1 in Second-line of Advanced Non-small Cell Lung Cancer
Anhui Chest Hospital
Phase 2 Unknown
NCT05448781 2022-07-07
Recombinant Human Angioendostatin /PD-1 Mab Combined With First-line Chemotherapy in the Treatment of Driver Gene Negative Advanced NSCLC
Affiliated Cancer Hospital & Institute of Guangzhou Medical University
Phase 2 Unknown
NCT05360979 2022-05-04
A Clinical Study of Immunotherapy Combined With Chemotherapy and Anti-angiogenic Therapy in Operable NSCLC
Second Xiangya Hospital of Central South University
Phase 2 Unknown
NCT03123445 2017-04-21
Endostar First-line Treatment of Advanced NSCLC
China Medical University, China
Phase 2 Unknown
NCT02005120 2013-12-20
Intrapleural Administration of Bevacizumab Versus Endostar for Pleural Effusions in NSCLC
Zhejiang University
Phase 2 Unknown
NCT01347424 2013-12-09
Evaluating Endostatin Plus TC Regimen in Secondary Malignant Neoplasm of Liver Using Contrast Enhancement Ultrasonography
Sun Yat-sen University
Phase 2 Unknown
NCT01218594 2012-10-17
DP-EN-RT
Sun Yat-sen University
Phase 2 Unknown
NCT01192230 2010-09-16
Study of Endostatin Combined With Docetaxel in the Treatment of Advanced Non-small Cell Lung Cancer Patients
Fudan University
Phase 2 Unknown
NCT01158144 2010-07-08
Concurrent Endostar, Paclitaxel/Carboplatin and Radiotherapy for Locally Advanced Non-small Cell Lung (RT0902)
Zhejiang Cancer Hospital
Phase 2 Unknown